Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2026-06-25 @ 3:44 AM
Study NCT ID:
NCT00358020
Status:
COMPLETED
Last Update Posted:
2006-12-04
First Post:
2006-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients
Sponsor:
University of Turin, Italy
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
X05141
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None